Symic Biomedical Garners $25,000,000 Series A Round

  • Feed Type
  • Date
    12/1/2015
  • Company Name
    Symic Biomedical
  • Mailing Address
    953 Indiana Street San Francisco, CA 94107 USA
  • Company Description
    Symic Biomedical is developing a new category of therapeutics that offer an exciting and biologically innovative approach to treating disease.
  • Website
    http://www.symicbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $25,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    We are now well capitalized to move our vascular and osteoarthritis programs through Phase 1/2 studies in the clinic and to continue the exciting research on what our next clinical program will be.
  • M&A Terms
  • Venture Investor
    Lilly Ventures
  • Venture Investor
    Undisclosed